Uncertainty in Decision Models Analyzing Cost-Effectiveness

Hunink MG , Bult JR , De Vries J , Weinstein MC Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making. 1998;18:337-46

Sonnenberg FA , Beck JR. Markov models in medical decision making: a practical guide Med Decis Making 1993;13:322-38

Williams DA. The analysis of binary responses from toxicological experiments involving reproduction and teratogenicity Biometrics 1975;31:949-52.

Sendi PP , Bucher HC , Craig BA , Pfluger D , Battegay M Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of highly active antiretroviral therapy . J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:376-81.

Sendi PP , Craig BA , Meier G , et al. and the Swiss Cohort Study. Cost effectiveness of preventing Mycobacterium avium complex (MAC) infection in HIV-infected patients in the era of highly active antiretroviral therapy J Antimicrob Ther, in press.

Hout BA van , Al MJ , Gordon GS , Rutten FFH. Costs, effects and C/E ratios alongside a clinical trial Health Econ 1994;3.309-19

Stinnett AA , Mullahy J Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Making 1998;18:S68-S80